Stay Updated with Annovis Bio Annovis Bio Inc. (NYSE: ANVS)
Join the Annovis Bio Investor Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Why Subscribe?
Get timely news on our clinical trials and research advancements.
Be the first to know about our webinars, conferences, and investor calls.
Stay informed with communication directly from our team.
About Annovis Bio Inc.: Headquartered in Malvern, Pennsylvania, Annovis Bio Inc. is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients. For more information, visit www.annovisbio.com and follow us on LinkedIn, YouTube, and X.
Contact Us
For any questions or further information, please contact us at: IR@annovisbio.com
